Leerink Swann Upgrades Genomic Health Inc. (GHDX) to Outperform on Catalysts
Tweet Send to a Friend
Leerink Swann upgraded Genomic Health Inc. (NASDAQ: GHDX) from Market Perform to Outperform and raised its valuation range from $30 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
